GXH — Green Cross Health Share Price
Last trade - 00:00- NZ$103.39m
- NZ$230.77m
- NZ$503.92m
- 84
- 99
- 64
- 95
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.66 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 2.2 | ||
| Price to Sales | 0.2 | ||
| EV to EBITDA | 4.43 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.06% | ||
| Return on Equity | 7.84% | ||
| Operating Margin | 6.42% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 568.53 | 570.4 | 478.09 | 493.61 | 503.92 | n/a | n/a | -2.34% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +4.63 | +0.59 | +22.64 | -27.63 | -16.8 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Green Cross Health Limited is a provider of primary healthcare services. The Company provides support, care, and advice to its communities through its pharmacies, medical centers, and community health services. The Company operates through two segments: pharmacy services and medical services. The pharmacy services segment provides retail and dispensary services, the medical services segment provides general practitioner (GP), nursing, and urgent care services. The Company offers pharmacy services through consolidated stores, equity accounted investments, and franchise stores. The medical services segment includes fully owned and equity accounted medical centers, and support services provided to these medical centers, as well as medical centers. The Company's medical network provides general practice services across New Zealand with approximately 66 medical centers.
Directors
- Kimmitt Ellis CHM
- Rachael Newfield CEO
- Ben Doshi CFO
- Alison Wyk COO
- Androulla Kotrotsos GMG
- Jim Greenwood SEC
- Peter Williams DRC
- John Andrew Bagnall NED
- John Bolland NED
- Patrick Donald Davies NED
- Peter Merton NED
- Kenneth Orr IND
- Ian Sharp IND
- Carolyn Steele IND
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- January 11th, 1999
- Public Since
- March 29th, 2000
- No. of Shareholders
- 1,644
- No. of Employees
- 248
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- New Zealand Stock Exchange
- Shares in Issue
- 143,603,000
- Address
- Millennium Ctr, AUCKLAND, 1051
- Web
- https://www.greencrosshealth.co.nz/
- Phone
- +64 95719080
- Auditors
- KPMG
Latest News for GXH
Upcoming Events for GXH
Full Year 2025 Green Cross Health Ltd Earnings Release
Green Cross Health Ltd Annual Shareholders Meeting
FAQ
As of Today at 02:55 UTC, shares in Green Cross Health are trading at NZ$0.72. This share price information is delayed by 15 minutes.
Shares in Green Cross Health last closed at NZ$0.72 and the price had moved by -26.53% over the past 365 days. In terms of relative price strength the Green Cross Health share price has underperformed the ASX All Ordinaries Index by -29.57% over the past year.
The overall consensus recommendation for Green Cross Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Green Cross Health dividend yield is 6.25% based on the trailing twelve month period.
Last year, Green Cross Health paid a total dividend of NZ$0.05, and it currently has a trailing dividend yield of 6.25%. We do not have any data on when Green Cross Health is to next pay dividends.
We do not have data on when Green Cross Health is to next pay dividends. The historic dividend yield on Green Cross Health shares is currently 6.25%.
To buy shares in Green Cross Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of NZ$0.72, shares in Green Cross Health had a market capitalisation of NZ$103.39m.
Here are the trading details for Green Cross Health:
- Country of listing: New Zealand
- Exchange: NZC
- Ticker Symbol: GXH
Based on an overall assessment of its quality, value and momentum Green Cross Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Green Cross Health is NZ$2.20. That is 205.56% above the last closing price of NZ$0.72.
Analysts covering Green Cross Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Green Cross Health. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -1.75%.
As of the last closing price of NZ$0.72, shares in Green Cross Health were trading -10% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Green Cross Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NZ$0.72.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Green Cross Health's management team is headed by:
- Kimmitt Ellis - CHM
- Rachael Newfield - CEO
- Ben Doshi - CFO
- Alison Wyk - COO
- Androulla Kotrotsos - GMG
- Jim Greenwood - SEC
- Peter Williams - DRC
- John Andrew Bagnall - NED
- John Bolland - NED
- Patrick Donald Davies - NED
- Peter Merton - NED
- Kenneth Orr - IND
- Ian Sharp - IND
- Carolyn Steele - IND